Teva Pharmaceutical Industries Limited company logo
Teva Pharmaceutical Industries Limited logo

Teva Pharmaceutical Industries Limited (TEVA)

Summary

Current Price
As of today, TEVA price is $36.46, down -0.16% on
Current Price All-Time High
TEVA price is currently -49.58% below its historical high of $72.31 set on
Market Cap
TEVA current market cap is $42B, up +111.18% over the past 365 days
PE Ratio
TEVA current PE ratio is 61.31
Revenue
TEVA current annual revenue is $17.46B, up +5.26% year-over-year
Next Earnings
The next earnings release for TEVA is on

Profile

Company profile for Teva Pharmaceutical Industries Limited (TEVA)
MetricValue
Full NameTeva Pharmaceutical Industries Limited
TickerNYSE: TEVA
ExchangeNYSE
SectorHealthcare
IndustrySpecialty & Generic Drug Manufacturers
CountryIsrael
IPO
IndexesNot included
Websitetevapharm.com
Employees37,000

Key Metrics

Teva Pharmaceutical Industries Limited Key Details
MetricValueDate
Price$36.46
Price, 1D Change-0.16%
Market Cap$42B
TTM Dividend Yield-
PE Ratio61.31
Beta0.63
Revenue$17.46B
Revenue, 1Y Change+5.26%
EPS$1.22
EPS, 1Y Change+183.93%

Chart

SUGGESTED SERIES
Teva Pharmaceutical Industries Limited chart

Events

Teva Pharmaceutical Industries Limited Events
MetricValueDate
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-Dividend$0.09
Next Ex-DividendN/AN/A
Last Split2:1
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

TEVA Estimates
MetricValueDate
EPS$1.22
EPS Estimate$2.14N/A
EPS Est. Change+75.35%N/A
Revenue$17.46B
Revenue Estimate$16.58BN/A
Revenue Est. Change-5.03%N/A
Current Price$36.46
Price Target$40.50-
Price Tgt. Change+11.08%-

🔒 Log In To Unlock Full Data

EPS

TEVA EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
$2.47-$1.46-158.96%
$2.63$1.22-53.51%
$2.14N/A+75.35%
$3.07N/A+151.59%
TEVA EPS reported versus estimate values chart

Revenue

TEVA revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$16.42B$16.59B+1.01%
$16.91B$17.46B+3.27%
$16.58BN/A-5.03%
$17.30BN/A-0.89%
TEVA revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

TEVA Performance
MetricValueDate
Price, 1Y+107.87%
Price, 3Y+281.78%
Market Cap, 1Y+111.18%
Market Cap, 3Y+296.99%
Revenue, 1Y+5.26%
Revenue, 3Y+17.53%
EPS, 1Y+183.93%
EPS, 3Y+155.67%

🔒 Log In To Unlock Full Data

Technicals

TEVA Technical Indicators
MetricValueDate
Current Price$36.46
SMA 200$31.61
SMA 50$33.63
EMA 200$30.70
EMA 50$33.98
MACD$1.02
Beta0.63
ATR$1.04
14-Day RSI64.16
10-Day Volatility14.82%

Dividends

TEVA Dividends
MetricValueDate
Last Paid$0.09
UpcomingN/AN/A
Dividend Yield-
Total Dividend-
$0.00
0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

TEVA Income & Profitability
MetricValueDate
Revenue$17.46B
EPS$1.22
Gross Profit$8.97B
Gross Margin51.56%
Operating Income$3.98B
Operating Margin22.90%
Net Income$1.43B
Net Margin8.22%
EBITDA$4.99B

🔒 Log In To Unlock Full Data

Financial Health

TEVA Financial Health
MetricValueDate
Debt To Equity2.16
1.04
0.80
-
7
1.07

Valuations

TEVA Valuations
MetricValueDate
PE Ratio61.31
2.43
5.48
13.03
-N/A

Balance Sheet

TEVA Balance Sheet
MetricValueDate
Book Value$7.91B
$3.56B
$40.75B
$13.95B
$32.83B
$13.46B
Total Debt$17.23B
$1.82B
$2.53B

Expenses

TEVA Expenses
MetricValueDate
$15.97B
$4.99B
$8.43B
$0.00
$1.01B
$0.00
-$181.43M

Cash Flow

TEVA Cash Flow
MetricValueDate
$2.89B
-$519.09M
-$2.13B
Capex$504.97M
$2.38B

Recent analyst updates

TEVA Recent analyst updates
MetricValueDate
Barclays
Piper Sandler
Barclays
UBS
Truist Securities
Piper Sandler
JP Morgan
B of A Securities
Piper Sandler
Truist Securities

Analyst sentiment

Sentiment over the past month
TEVA analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
TEVA institutional ownership distribution chart

Screeners with TEVA

FAQ

What is the ticker symbol for Teva Pharmaceutical Industries Limited?
The ticker symbol for Teva Pharmaceutical Industries Limited is NYSE:TEVA
Does Teva Pharmaceutical Industries Limited pay dividends?
No, Teva Pharmaceutical Industries Limited does not pay dividends
What sector is Teva Pharmaceutical Industries Limited in?
Teva Pharmaceutical Industries Limited is in the Healthcare sector
What industry is Teva Pharmaceutical Industries Limited in?
Teva Pharmaceutical Industries Limited is in the Specialty & Generic Drug Manufacturers industry
What country is Teva Pharmaceutical Industries Limited based in?
Teva Pharmaceutical Industries Limited is headquartered in Israel
When did Teva Pharmaceutical Industries Limited go public?
Teva Pharmaceutical Industries Limited initial public offering (IPO) was on February 16, 1982
Is Teva Pharmaceutical Industries Limited in the S&P 500?
No, Teva Pharmaceutical Industries Limited is not included in the S&P 500 index
Is Teva Pharmaceutical Industries Limited in the NASDAQ 100?
No, Teva Pharmaceutical Industries Limited is not included in the NASDAQ 100 index
Is Teva Pharmaceutical Industries Limited in the Dow Jones?
No, Teva Pharmaceutical Industries Limited is not included in the Dow Jones index
When was Teva Pharmaceutical Industries Limited last earnings report?
Teva Pharmaceutical Industries Limited's most recent earnings report was on July 29, 2026
When does Teva Pharmaceutical Industries Limited report earnings?
The next expected earnings date for Teva Pharmaceutical Industries Limited is November 4, 2026

Data Sources & References

  1. TEVA Official Website www.tevapharm.com
  2. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/818686/000119312526034532/0001193125-26-034532-index.htm
  3. TEVA Profile on Yahoo Finance finance.yahoo.com/quote/TEVA
  4. TEVA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/teva